Xeristar – Drug Insight, 2019-2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Xeristar – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Xeristar – Drug Insight, 2019 highlights…
Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Xeristar – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Xeristar – Drug Insight, 2019 highlights…
PASADENA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24arwr&src=ctag" target="_blank"gt;$arwrlt;/agt; lt;a href="https://twitter.com/hashtag/ILC2019?src=hash" target="_blank"gt;#ILC2019lt;/agt;–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the presentation of clinical data from…
Transaction on Track to Close in Third Quarter of 2019 NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) today announced that…
SC Liver Research Consortium and Perspectum Diagnostics develop major US clinical network This will provide clinical trial services supporting drug…
SUMMIT, N.J.–(BUSINESS WIRE)–Celgene Corporation (NASDAQ: CELG) today announced that its stockholders have voted to approve the company’s proposed combination with…
DUBLIN–(BUSINESS WIRE)–The “North America Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market – Growth, Trends, and Forecast (2019 – 2024)” report…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/MarketIntelligence?src=hash" target="_blank"gt;#MarketIntelligencelt;/agt;–SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their procurement market…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Research?src=hash" target="_blank"gt;#Researchlt;/agt;–The global colorectal cancer therapeutics market is expected to post a CAGR of close to 3% during…
Proof-of-concept trial to evaluate safety and biomarkers of cancer cell mobilization in patients with hormone receptor positive metastatic breast cancer…